Atico Pharma Egypt is targeting sales of $10 million by the end of this year, representing a 50% increase, according to CEO Waheed Atique.
Atique stated that the company plans to increase its exports to $6 million during the year 2026, compared to $4 million in exports achieved by the end of last year. The company operates a factory in the Suez Canal Economic Zone dedicated to producing various types of intravenous medical solutions.
Details of the Expansion
Atique explained that the factory includes two production lines and spans an area of 20,000 square meters, allowing for optimal utilization of space. He also mentioned that the company intends to add a third production line next year to increase production capacity and expand into foreign markets.
The company currently has a portfolio of about 25 products, with plans to increase this to over 30 products by the end of 2026, aiming to fill the import gap in strategic intravenous solutions.
Background & Context
Atico Pharma aims to expand its exports to several European markets such as Italy, Belgium, Norway, and Hungary in the upcoming period. Currently, the company exports its products to 13 Arab and African countries, including Libya, Sudan, Yemen, and Iraq, in addition to having a presence in COMESA countries and some Latin American markets.
Last week, Mustafa Madbouly, the Prime Minister, inaugurated the second phase of Atico Pharma's factory within the industrial developer Orascom's integrated industrial area in Sokhna, with investments amounting to $10 million, raising the total investment in the project to $60 million.
Impact & Consequences
The production capacity of the expansions is 15 million bottles annually, increasing the total production capacity to 50 million bottles of intravenous medical solutions per year. The factory relies on the latest global technologies in this field and complies with Good Manufacturing Practices (GMP).
This expansion reflects the company's commitment to meeting local and international market needs and enhances Egypt's ability to export medical products, contributing to the support of the national economy.
Regional Significance
The success of Atico Pharma in achieving its export goals is an important step towards enhancing the pharmaceutical industry in the Arab region. It also reflects the ability of Egyptian companies to compete in global markets, which contributes to improving the image of the Egyptian industry on the international stage.
In conclusion, Atico Pharma aims to strengthen its position in the market by increasing production and expanding into foreign markets, reflecting an ambitious growth strategy aimed at achieving sustainability and competitiveness in the pharmaceutical industry.